Ambeed.cn

首页 / / / / Pifithrin-μ

Pifithrin-μ {[allProObj[0].p_purity_real_show]}

货号:A370437 同义名: 2-Phenylethynesulfonamide; PFTμ

Pifithrin-μ 是一种 p53 和 HSP70 的抑制剂,具有抗肿瘤和神经保护作用。

Pifithrin-μ 化学结构 CAS号:64984-31-2
Pifithrin-μ 化学结构
CAS号:64984-31-2
Pifithrin-μ 3D分子结构
CAS号:64984-31-2
Pifithrin-μ 化学结构 CAS号:64984-31-2
Pifithrin-μ 3D分子结构 CAS号:64984-31-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Pifithrin-μ 纯度/质量文件 产品仅供科研

货号:A370437 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 p53 其他靶点 纯度
Pifithrin-μ 99%+
Pifithrin-α HBr 98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 Autophagy 其他靶点 纯度
SBI-0206965 +++

ULK2, IC50: 711 nM

ULK1, IC50: 108 nM

95%
Hydroxychloroquine sulfate 99%
Valproic acid sodium HDAC 97%
PFK-015 ++

PFKFB3, IC50: 207 nM

99%+
MRT68921 HCl ++++

ULK2, IC50: 1.1 nM

ULK1, IC50: 2.9 nM

99%+
ROC-325 99%+
Autophinib +++

Autophagy, IC50: 40 nM

99%
Lys05 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Pifithrin-μ 生物活性

靶点
  • p53

描述 Hot shock protein 70(HSP70) is an ATP-dependent chaperone that can be induced by cellular stress and its aberrant activation is commonly observed in various malignancies. Pifithrin-μ is an inhibitor of inducible HSP70. It strongly inhibited cell viability with IC50 values of 2.5, 6.1, 4.4, 6.1, 12.7, 8.4 and 11.2 μM in NALM-6, TOM-1, BE-13, Jurkat, KG-1a, K562 and K562-r cells, respectively. In NALM-6 and KG-1a cell lines, incubation with Pifithrin-μ (4 and 5 μM for NALM-6; 40 and 60 μM for KG-1a) for 24h caused a remarkably reduced proportion of cells in S phase. Around 22% of NALM-6 cells were observed in the sub-G0/1 fraction after incubation with 5μM Pifithrin-μ, while only 2% of KG-1a cells were within this fraction after 60 μM Pifithrin-μ treatment. Incubation of NALM-6 cells with Pifithrin-μ at 4, 5 and 6.5 μM resulted in 34, 59 and 80% apoptotic cells above spontaneous apoptosis, respectively. Moreover, the intracellular AKT and ERK1/2 levels in NALM-6 cells was decreased by 10-h incubation of 10μM Pifithrin-μ[3]. In nude mice inoculated with human pancreatic cancer MiaPaca-2 cells, intraperitoneal injection with Pifithrin-μ (25mg/kg, 100μL) significantly enhanced the inhibitory effect of TRAIL on MiaPaca-2 tumor growth[4].

Pifithrin-μ 细胞实验

Cell Line
Concentration Treated Time Description References
HepG2 cells 5 µM 1 hour Pretreatment with Pifithrin-μ significantly alleviated GOX-induced mitochondrial dysfunction, including the loss of mitochondrial membrane potential, mitochondrial swelling, and the decrease in ATP levels. Int J Biol Sci. 2016 Jan 1;12(2):198-209.
BCBL1 PEL cells 20 µM 12-48 hours PES treatment increased cell death between 12 and 48 hours in both BC3 and BCBL1 cells, indicating time-dependent cytotoxicity. Cell Death Dis. 2013 Jul 18;4(7):e730.
BC3 PEL cells 10-30 µM 24 hours PES induced a dose-dependent cytotoxic effect in BC3 and BCBL1 PEL cells, leading to lysosome membrane permeabilization, relocation of cathepsin D to the cytosol, Bid cleavage, mitochondrial depolarization, and ultimately programmed cell death. Cell Death Dis. 2013 Jul 18;4(7):e730.
SNU886 cells 5 µM 24 hours Pifithrin-μ disrupted the interaction between CREB1 and CREBBP, reduced the mRNA levels of CREB1 target genes, and suppressed SESN3 expression, thereby enhancing sorafenib-induced cell death. Cell Death Dis. 2025 Jan 26;16(1):42.
HCCLM3 cells 10 µM 24 hours Pifithrin-μ inhibited HSP70 to reduce the transcriptional activity of CREB1 and the expression of SESN3, consequently enhancing sorafenib-induced ferroptosis in mTOR-activated liver cancer cells. Cell Death Dis. 2025 Jan 26;16(1):42.
KG-1a (AML) 0.5 to 100 µM 48 hours PFT-μ significantly inhibited cell viability at low micromolar concentrations in all cell lines tested, with IC50 values ranging from 2.5 to 12.7 μM, and was highly active in primary AML blasts with a median IC50 of 8.9 μM. PFT-μ induced apoptosis and cell cycle arrest in a dose-dependent manner in AML and ALL. Blood Cancer J. 2011 Jul;1(7):e28.
NALM-6 (B-precursor ALL) 0.5 to 100 µM 48 hours PFT-μ significantly inhibited the viability of NALM-6 cells, with an IC50 value of 2.5 μM. PFT-μ led to an increase in the active form of caspase-3 and reduced intracellular concentrations of AKT and ERK1/2. Blood Cancer J. 2011 Jul;1(7):e28.
TOM-1 (B-precursor ALL; BCR-ABL positive) 0.5 to 100 µM 48 hours PFT-μ significantly inhibited the viability of TOM-1 cells, with an IC50 value of 6.1 μM. PFT-μ enhanced the cytotoxicity of cytarabine, 17-AAG, SAHA, and sorafenib in TOM-1 cells. Blood Cancer J. 2011 Jul;1(7):e28.
HONE1/Akata cells 40 µM 48 hours PES significantly decreased the expression of EBNA1, independent of effects on EBNA1 transcription or proteasomal degradation. Cell Death Dis. 2018 Jun 29;9(7):734.
HK1/Akata cells 40 µM 48 hours PES significantly decreased the expression of EBNA1, independent of effects on EBNA1 transcription or proteasomal degradation. Cell Death Dis. 2018 Jun 29;9(7):734.
B95-8 cells 10 µM 48 hours PES significantly decreased the expression of EBNA1, independent of effects on EBNA1 transcription or proteasomal degradation. Cell Death Dis. 2018 Jun 29;9(7):734.

Pifithrin-μ 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c Nude mice Subcutaneous xenograft model Intraperitoneal injection (Pifithrin-μ), Oral administration (sorafenib) 10 mg/kg Every other day, until the end of the experiment Combined treatment of Pifithrin-μ and sorafenib significantly inhibited tumor growth in mTOR-activated liver cancer cells, reduced tumor volume and weight, and had no significant impact on the body weight of mice. Cell Death Dis. 2025 Jan 26;16(1):42.
WT and Traf6−/− mice Traf6−/− mice Intraperitoneal injection 10 mg/kg Every other day for one week Pifithrin-μ reversed the spontaneous apoptosis in Traf6?/? thymus, while pifithrin-α did not have this effect Mol Cell. 2016 Nov 17;64(4):803-814
BALB/c Nude mice HONE1/Akata cell-induced tumor model Intraperitoneal injection 8 mg/kg Once daily for 5 consecutive days PES significantly inhibited the growth of tumors induced by HONE1/Akata cells and reduced the expression of EBNA1 in tumor tissues. Cell Death Dis. 2018 Jun 29;9(7):734.
C57BL/6J mice Cisplatin-induced cognitive impairment model Intraperitoneal injection 8 mg/kg Once daily for two 5-day cycles PFT-μ completely prevented cisplatin-induced cognitive impairment and associated structural changes in the brain, including loss of white matter integrity and neurogenic areas. Cancer Res. 2017 Feb 1;77(3):742-752

Pifithrin-μ 动物研究

Dose Mice: 1 mg/kg or 5 mg/kg[3] (i.p.), 40 mg/kg[2] (i.p.)
Administration i.p.

Pifithrin-μ 参考文献

[1]Kaiser M, Kuhnl A, et al. Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia. Blood Cancer J. 2011 Jul;1(7):e28.

[2]Strom E, Sathe S, et al. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol. 2006 Sep;2(9):474-9. Epub 2006 Jul 23.

[3]Kaiser M, Kühnl A, Reins J, Fischer S, Ortiz-Tanchez J, Schlee C, Mochmann LH, Heesch S, Benlasfer O, Hofmann WK, Thiel E, Baldus CD. Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia. Blood Cancer J. 2011 Jul;1(7):e28. doi: 10.1038/bcj.2011.28. Epub 2011 Jul 15. PMID: 22829184; PMCID: PMC3255249.

[4]Monma H, Harashima N, Inao T, Okano S, Tajima Y, Harada M. The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancer. Mol Cancer Ther. 2013 Apr;12(4):341-51. doi: 10.1158/1535-7163.MCT-12-0954. Epub 2013 Jan 31. PMID: 23371857.

Pifithrin-μ 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.52mL

1.10mL

0.55mL

27.59mL

5.52mL

2.76mL

55.18mL

11.04mL

5.52mL

Pifithrin-μ 技术信息

CAS号64984-31-2
分子式C8H7NO2S
分子量 181.21
SMILES Code O=S(C#CC1=CC=CC=C1)(N)=O
MDL No. MFCD00181531
别名 2-Phenylethynesulfonamide; PFTμ; PFT-µ; Pifithrin-µ; NSC 303580
运输蓝冰
InChI Key ZZUZYEMRHCMVTB-UHFFFAOYSA-N
Pubchem ID 327653
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(579.43 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。